India Prepares For Massive Vaccine Drive, But Some Fear It's Moving Too Quickly

published 13.01.2021 05:52

Image of article 'India Prepares For Massive Vaccine Drive, But Some Fear It's Moving Too Quickly'
Share

When India's regulator announced the vaccine's approval on Jan. 3, it said it was aimed at offering more options, in addition to the AstraZeneca formula, given that a more infectious COVID strain had been discovered in the UK.

The shipments consist of two formulas: One developed by Oxford University and the pharmaceutical giant AstraZeneca, and another vaccine developed by an Indian company called Bharat Biotech — billed as India's first "indigenous" vaccine.

Dheeraj Dhawan/Hindustan Times via Getty Images hide caption toggle caption Dheeraj Dhawan/Hindustan Times via Getty Images A box for COVID-19 vaccine storage, at Aishbagh on Tuesday, in Lucknow, India.

In the case of the Bharat Biotech vaccine, "the approval process in India was a secret," Thakur says.

Similar Posts